8.45
price up icon1.93%   0.16
after-market Handel nachbörslich: 8.60 0.15 +1.78%
loading

Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
18.97%
3.289
4.059 5.3275 5.1308 4.9011
Interest Income/Expense
0.00971
- - - -
Operating Income/Loss
18.97%
-3.289
-4.059 -5.3275 -5.1308 -4.9011
Nonoperating Income/Loss
32.68%
-0.0378
-0.0285 0.0276 0.7892 0.0842
Income/Loss From Continuing Operations Before Tax
18.61%
-3.3268
-4.0875 -5.30 -4.3417 -4.8169
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.61%
-3.3268
-4.0875 -5.30 -4.3417 -4.8169
Net Income/Loss
18.61%
-3.3268
-4.0875 -5.30 -4.3417 -4.8169
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
436.13%
5.1424
-1.5299 3.1572 1.3195 14.40
Diluted Average Shares
436.13%
5.1424
-1.5299 3.1572 1.3195 14.40
Basic Earnings Per Share
99.32%
-0.65
-95.15 -1.68 -3.29 -0.33
Diluted Earnings Per Share
99.32%
-0.65
-95.15 -1.68 -3.29 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):